Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma

Carter, 1989, Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases, Cancer, 63, 181, 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H Fisher, 1983, Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update, Cancer, 52, 1551, 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3 1998, Polychemotherapy for early breast cancer: an overview of the randomised trials, Lancet, 352, 930, 10.1016/S0140-6736(98)03301-7 Goldhirsch, 2011, Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011, Ann Oncol, 22, 1736, 10.1093/annonc/mdr304 Van Zee, 2003, A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy, Ann Surg Oncol, 10, 1140, 10.1245/ASO.2003.03.015 Alran, 2007, Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy, Ann Surg Oncol, 14, 2195, 10.1245/s10434-006-9331-2 Reyal, 2011, The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma, PLoS One, 6, e20297, 10.1371/journal.pone.0020297 Freneaux, 2002, Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice, Mod Pathol, 15, 641, 10.1038/modpathol.3880580 Bevilacqua, 2007, Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation, J Clin Oncol, 25, 3670, 10.1200/JCO.2006.08.8013 Viale, 2005, Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution, Cancer, 103, 492, 10.1002/cncr.20809 Ravdin, 1994, Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators, J Natl Cancer Inst, 86, 1771, 10.1093/jnci/86.23.1771 Gann, 1999, Factors associated with axillary lymph node metastasis from breast carcinoma: descriptive and predictive analyses, Cancer, 86, 1511, 10.1002/(SICI)1097-0142(19991015)86:8<1511::AID-CNCR18>3.0.CO;2-D Crabb, 2008, Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer, Clin Breast Cancer, 8, 249, 10.3816/CBC.2008.n.028 Lu, 2008, Predicting features of breast cancer with gene expression patterns, Breast Cancer Res Treat, 108, 191, 10.1007/s10549-007-9596-6 Lee, 2010, Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1–2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size, Cancer Res Treat, 42, 30, 10.4143/crt.2010.42.1.30 Van Calster, 2009, Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive, Breast Cancer Res Treat, 113, 181, 10.1007/s10549-008-9914-7 Hwang, 2003, Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer, Ann Surg Oncol, 10, 248, 10.1245/ASO.2003.05.020 Degnim, 2005, Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram, Am J Surg, 190, 543, 10.1016/j.amjsurg.2005.06.008 Pal, 2008, A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive, Br J Surg, 95, 302, 10.1002/bjs.5943 Kohrt, 2008, New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients, BMC Cancer, 8, 66, 10.1186/1471-2407-8-66 Barranger, 2005, An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement, Breast Cancer Res Treat, 91, 113, 10.1007/s10549-004-5781-z Saidi, 2004, Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer, Am Surg, 70, 101, 10.1177/000313480407000202 Krag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, 11, 927, 10.1016/S1470-2045(10)70207-2 Giuliano, 2010, Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial, Ann Surg, 252, 426, 10.1097/SLA.0b013e3181f08f32 Giuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001/jama.2011.90 Lucci, 2007, Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011, J Clin Oncol, 25, 3657, 10.1200/JCO.2006.07.4062 Montgomery, 2002, Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer, Anesth Analg, 95, 385, 10.1213/00000539-200208000-00026 Mansel, 2006, Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial, J Natl Cancer Inst, 98, 599, 10.1093/jnci/djj158 Fleissig, 2006, Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer, Breast Cancer Res Treat, 95, 279, 10.1007/s10549-005-9025-7 Mendez, 2005, Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?, Ann Surg Oncol, 12, 24, 10.1007/s10434-004-1169-x Martelli, 2011, Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up, Ann Surg Oncol, 18, 125, 10.1245/s10434-010-1217-7 Rudenstam, 2006, Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93, J Clin Oncol, 24, 337, 10.1200/JCO.2005.01.5784